Abstract-A multiplex polymerase chain reaction (PCR) for identification of four viruses causing acute res piratory diseases in human beings was developed. The analytical sensitivity of developed RT PCR for iden tification of adenovirus, respiratory-syncytial virus, flu viruses types A and B, and actual subtypes of type A flu virus (seasonal and pandemic variants H1N1, seasonal H3N2, and viruses of bird flu that are pathogenic to human beings H5 and H7) was 1 × 10 3 genome equivalents per milliliter. Diagnostic sensitivity for flu virus type A and B, and also subtypes H1 (seasonal H1N1, pandemic variant of H1N1 of year 2009), H3, H5 was 1 × 10 3 -10 4 viral particles per milliliter. The method developed has high specificity and does not have positive signal in experiments with DNA/cDNA of human beings and viral DNA. We have studied 50 samples using the developed set. Etiology was defined in 33 samples.
INTRODUCTION
Acute respiratory infections are primary in terms of common infectious morbidity, being the main reason for temporary disability, leading to significant eco nomic losses. According to official data provided by the Federal Service for Monitoring of Consumer Rights Protection and Human Welfare, 28265634 cases of acute respiratory infections of upper airways were offi cially registered in 2010 in the Russian Federation, including flu, while in 2011 31038446 cases were [18] . The real number of cases of acute respiratory infec tions may be greater, because some infected people do not ask for medical help and are not reported statisti cally.
Viruses of six families are the main etiology agents of human viral respiratory diseases: Orthomyxoviridae (flu virus), Paramyxoviridae (paraflu, metapneumovi rus, respiratory syncytial virus), Picornaviridae (enterovirus, rhinovirus), Coronaviridae (coronavi ruses 229E, NKU1, NL63, OC43, SARS agent), Ade noviridae (adenovirus), and Parvoviridae (bokavirus). Because acute respiratory infections in human beings are caused by a wide range of infectious agents, differ ential diagnosis of them requires significant material, time, and labor. In connection with this, developing tools fir differential diagnosis of respiratory infections in the form of multiplex PCR is very relevant [8] . This work is devoted to development and validation of the set of reagents to detect genetic material of four viruses (flu viruses type A and B, respiratory syncytial virus, and adenovirus), causing the most severe infections of human respiratory tract.
MATERIALS AND METHODS

Clinical samples.
Clinical material (swabs from naso and oro pharynx) from 30 patients without any symptoms of ARI were used to conduct the study. The study was carried out following principles of consent and confidentiality in accordance with the "Basis The strains of flu virus had at least three passages on the MDCK cellular culture at Vector. The strain of res piratory syncytial virus was obtained on transplant able cellular culture of kidney of green monkey Vero and the strain of adenovirus on transplantable culture of modified cells of human embryo kidney 293. The cells were obtained from the Department of Cellular Technologies of Vector. Cultivation of infected cellular cultures was conducted at 37°C in atmosphere con taining 5% of CO 2 . The cultivation medium DMEM (Biolot, Moscow) with addition of 2 mM per 1 L of glutamine (Sigma Aldrich, United States) and antibi otics in the amount of penicillin 100 ME/mL and 100µ/mL of streptomycin was used for maintenance of cellular cultures.
Primers and probes. Nucleotide sequences obtained from the GenBank international database were used to select primers and probes. To equalize the obtained sequences, as well as for analysis and calcula tion of primers and probes and studying their specific ities, the Vector NTI v. 9.0 family of computer pro grams (Informax, United States) and the internet database of the US National Center of Biotechnology Information (NCBI) were used in an online regime.
Positive control samples. Positive control samples were obtained by the method of TOPO T/A cloning of a synthesized DNA fragment with viral insertion into the pCR2.1 plasmid (Invitrogen, United States) for transformation.
Detection of DNA concentration. The concentra tions of plasmid and genomic DNA of human beings were detected using the Quant iT DNA HS commer cial reagent set (Invitrogen, United States) and QUIBIT fluorometer (Invitrogen, United States).
Obtaining the samples of flu virus and detection of physical titer. To detect the virus concentration of (physical titer), specimens prepared in the following way were used. On the fifth day of infection, cultural virus containing fluid (CVF) was taken from cultural vessels. Further cellular debris was removed by centri fuging at 6000 g at 4°C for 10 min, and PEG was then added to subprecipitate fluid to a final concentration of 8% (mass/volume). The obtained suspension was mixed for 1 h at 4°C and then centrifuged for 20 min at 1000 g. The precipitate obtained was resuspended in STE buffer (10 mM Tris HCl, pH 7.8, 100 mM NaCl, 1 mM EDTA), and then the suspension was applied to a gradient from 10-60% (mass/volume) sucrose solu tions. Centrifuging was conducted for 4 h at 150000 g by the means of an Optima L 90K ultracentrifuge in a 90Ti rotor (Beckman Coulter, United States). Frac tions containing a maximum amount of flu virions in correspondence with the results of hemagglutination reaction, were applied to prepare consecutive tenfold dilutions and determine the diagnostic sensitivity of the developed set of reagents.
Extraction of viral and human RNA/DNA, reaction of reverse transcription. Viral and human RNA/DNA were isolated from 100 µL of clinical material, CVF, whole blood. Isolation was done using the RIBO prep commercial set of reagents ( (HA gene) were analyzed, respectively. For human respiratory-syncy tial and human adenovirus, original primers and probes were selected, but their nucleotide sequences are to be published in future works due to forthcoming patent ing. In the calculation, 1562 nucleotide sequences of the genome of respiratory-syncytial virus and 1393 nucleotide sequences of adenovirus of serotypes 3, 4, 7, 14, and 21 most often infecting the human respi ratory tract [10, 15] were analyzed. Primers and probe for detection of respiratory-syncytial virus were selected inside the F gene and for adenovirus inside the hexon gene. Nucleotide sequences of primers and probes are presented in the table. The specificities of selected oligonucleotides was analyzed at the stage of calculations using the Nucleotide Blast NCBI pro gram. According to the results of our investigations, the selected primers and probes had no homology with human DNA or with agents that could be observed in swabs from feces, nasopharynx, oropharynx, aspirate, and other clinical materials chosen for diagnostic studies, namely, with human coronaviruses types 229E, NL63, OC43, and NKU1; coronavirus associ ated with severe acute respiratory syndrome human herpes virus type 1-2; cytomegalovirus; human paraflu virus type 1-4; metapneumovirus; human rhi novirus types A-C; bacteria of the genus Streptococ cus; and bacteria of the species Mycoplama pneumo nia, Chlamydophila pneumonia, Haemophilus flu, and Legionella pneumophila.
Plasmid constructions with an inserted corre sponding virus specific DNA fragment were used in the developed set as positive controls. The obtained plasmid structures (pIV A, p IV B, pA/H1N1seas, pA/H1N1(2009)pand, pA/H3, pA/H5, pA/H7, pAdV, pPCB) were used for optimization of amplifica tion reaction conditions for each infectious agent sep arately (monoplex PCR). Experimentally optimal concentrations of Mg 2+ (2.5 mM MgCl 2 ), direct and reverse primers (10-12 pM), and fluorescent DNA probe (6-8 pM) were chosen for PCR in monovariant forms.
At the next stage of work, multiplex PCR con ducted in three mixtures was optimized and verified (Fig. 1) . The first mixture included four pairs of prim ers and four DNA probes; the second, three; and the third, two. The developed multiplex variant of PCR was also optimized according to the amount of Mg 2+ ions (2.5 mM MgCl 2 ), probe (8 pM), and direct and reverse primers, the concentrations of which were Vol. 28 No. 4 2013 higher than in the monoplex PCR variant (15-17 pM). The amplification reaction in the format "multiplex" was optimized for annealing of primers at a tempera ture 51°C.
The obtained plasmid constructions were also used to evaluate the effectiveness of real time PCR, for the purposes of which successive tenfold dilutions of control plasmid DNA with virus specific DNA inser tion were prepared. The threshold of the method's sen sitivity was 1 × 10 3 GE/mL (Figs. 2a-2c ).
The sensitivity and specificity of the developed set were determined both in monovariant and "multi plex" formats. In the experiments with samples with a known concentration of the virus (physical titer), we detected the diagnostic sensitivity of flu viruses A and B, seasonal flu virus A/H1N1, pandemic flu virus of swine origin A/H1N1(2009), an flu virus A subtypes H3 and H5, which is 1 × 10 3 -10 4 virions per milliliter (Fig. 2d) according to the experimental data. Thus, the sensitivity that was obtained of the developed set of reagents complies with the requirements for test sys tems recommended for use in clinical practice.
Th developed set of reagents was checked at the first stage using viral strains from the collection of The specificity that we identified empirically is an important characteristic of the set that has been devel oped. This set does not have a positive signal when 3 µg of human genome DNA/cDNA are added to each mixture. A nonspecific signal was also absent in exper iments on cDNA of coronavirus associated with (Fig. 3) . In 29 of the studied samples, RNA of flu virus A was detected (58%), while RNA of flu virus B (8%) was found in 4. In 
